DKDerya Kilic

Derya Kilic

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Derya Kilic has a total of 58 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Is there a threshold for the inseminated progressive motile sperm count in intrauterine insemination? A retrospective cohort study of 564 cycles

    by Cihan Kabukçu, Derya Kılıç

    Purpose: To examine the association between inseminated progressive motile sperm count (IPMSC) and pregnancy test positivity after intrauterine insemination (IUI), and to identify a useful threshold.Materials and methods: This retrospective cohort study included 564 IUI cycles in 364 women treated between January 2025 and July 2026. Semen samples were prepared by density-gradient centrifugation followed by swim-up, and 0.5 mL was inseminated. IPMSC was calculated from post-wash concentration and insemination volume. IPMSC was analysed categorically and continuously and compared with pre-wash counts. Associations were assessed using generalized estimating equations, with patient identity as the clustering variable.Results: Pregnancy test positivity was 12.2% per cycle and 19.0% per woman. Pre-wash sperm parameters did not differ between positive and negative cycles. Median IPMSC was higher in positive cycles (15.0 vs 10.0×10⁶, p=0.012). One of 76 cycles with an IPMSC below 2×10⁶ had a positive test (1.3%), compared with 13.9% at or above this level (p

  • Congenital Anomaly Prevalence: A 10‐Year Retrospective Study in a Tertiary Hospital in Turkey

    by Hülya Çetin, Serhan Sorkun, İlknur Lafcı, Derya Kılıç, Babür Kaleli, Özmert Muhammet Ali Özdemir, Bilgin Kıray Vural

    Objective: Congenital anomalies (CA) are health problems that can significantly affect individuals, families, health systems, and society. Our aim is to present the characteristics of CA observed in babies born at our institution between 2014 and 2023, including the Covid‐19 pandemic period. Materials and Methods: Retrospective data obtained from the delivery room records and hospital information system of Pamukkale University Hospital were analyzed. Results: During the 10‐year period covered by our study at our institution, 16,030 births occurred, and 941 (5.87%) newborns were diagnosed with CA. The most common anomalies were cardiovascular system (CVS) (42%), other congenital malformations (5%), musculoskeletal system (4%), and central nervous system (CNS) anomalies (7%). Two hundred twenty‐nine newborns (24%) were found to have multiple congenital anomalies. The prevalence of CA was higher in 2020, 2021, and 2022 (during the COVID‐19 pandemic) compared to other years. The mortality rate among newborns with CA was 21.25%. Of the CA babies who died, 37.5% had CVS, 30% had multiple anomalies, and 9% had CNS anomalies. The mortality rate due to congenital anomalies, based on the total number of births in our hospital, was 1.25%. Conclusion: We found that the mortality rate among newborns with CA was 21.25% and that the incidence of anomalies increased during the COVID‐19 pandemic. Multidisciplinary efforts are required to provide parents with the necessary information during pregnancy and the prepregnancy planning period. It is crucial to examine the prevalence of CA during the Covid‐19 pandemic period in other regional studies and to evaluate the impact of such epidemics on anomalies.

  • Open Access

    A Decrease in Lactobacilli in the Vaginal Microbiota Is Independently Associated With HPV Persistence in Women With High-Risk HPV Infection

    by Elif Avsaroglu, Babur Kaleli, Derya Kilic, Ilknur Kaleli, Tolga Guler

    Background Vaginal dysbiosis, an imbalance between species, can initiate some local changes in immune and metabolic signaling causing chronic inflammation. The mechanism of the clearance or progression of the HPV infection has not been uncovered yet. We hypothesized that vaginal dysbiosis may contribute to the persistence of the cervical HPV infection. Therefore we aimed to determine the association of lactobacillus dominancy index with cervical HR-HPV persistence. Methods A total of 100 women who were followed up because of high-risk HPV infection were defined as the target study group. The patients were evaluated in two groups; HPV positive (group with HPV persistence, n=43) and HPV negative (group with HPV clearance, n=57). Cervicovaginal swab samples and blood samples were evaluated for Nugent score, lactobacillus dominance, and white blood cell count. Statistical tests were performed by the IBM Statistical Product and Service Solutions (version 22, IBM SPSS Statistics for Windows, Armonk, NY) program. The continuous variables were presented using the mean±standard deviation (SD), and the categorical variables were presented as the number of cases and their percentage. A p value less than 0.05 (<0.05) was set as statistically significant. Results HPV persistence was observed in 43 (43%) patients. Univariate analysis revealed that age, menopausal status, and lactobacillus reduction were associated with HPV persistence (p<0.05). The median value of the Nugent score was similar among groups. After logistic regression analysis, lactobacillus reduction continued to be associated with HPV persistence, independent of age and menopause (OR: 2.668, 96% CI: 1.069-6.662, p<0.05) Conclusions A decrease in lactobacilli in the cervicovaginal microbiota is associated with the persistence of HPV, regardless of age and menopausal status in this study.


  • Open Access

    Is the Anal Component of the Anogenital HPV-Related Disease Overlooked During the Surveillance of Patients Treated for Cervical Intraepithelial Neoplasia?

    by Utku Ozgen, Tolga Guler, Derya Kilic, Ali Gokakin, Muhammed Aykota, Ilknur Kaleli, Yeliz Arman Karakaya, Ugur Sungurtekin, Muhammed Aykota Iii

    Aim: To investigate the anal component of the anogenital Human Papillomavirus (HPV) related disease during surveillance of patients treated for cervical intraepithelial neoplasia (CIN). Methods: Patients were analyzed within two groups according to the histopathological examination of the cervical biopsies: Low-Grade Squamous Intraepithelial Lesion (LSIL) and High-Grade Squamous Intraepithelial Lesion (HSIL) groups. Anal specimens were also collected in the first-year follow-up visit. Results: All patients had cervical high-risk HPV (HR HPV) infection at admission. At the first-year follow-up, positive HR HPVs were found in 47% of cervical samples. Despite this clearance, the anal HPV infection rate after the first year was 42.5% and 39.6% in LSIL and HSIL groups. Amongst the HSIL group, anal HR HPV positivity was observed in 29.6% of cases without any cervical HPV infection. Conclusion: A group of women cured of high-grade lesions have ongoing anal HPV infection. It is reasonable to propose that detecting anal HPV could impact the patient's treatment process. Therefore, prospective studies are needed to investigate this group of women's clinical outcomes and define the clearance rate of cervical HPV infection when anal HPV persists.


  • Open Access

    ABDOMINAL WALL SCAR ENDOMETRIOSIS AFTER CESAREAN SECTION; A RARE CASE REPORT WITH MULTI FOCUS

    by Ayhan Atigan, Derya Kiliç, Yeliz Arman Karakaya, Ömer Tolga Güler

    Endometriosis is described as the presence of functional endometrial tissue outside the uterine cavity. Scar endometriosis (SE) is a rare condition which usually develops after gynecologic operations involving the uterus and fallopian tubes. The symptoms are usually nonspecific and cyclic incisional pain increasing by menstruation is the most common symptom. Diagnosis of the disease can be difficult and may be confusing with various other post-surgical conditions. Histopathological examination reveals the final diagnosis. This article presents a case with cesarian SE of which the largest reaches 5x4x3 cm with multiple foci. Scar endometriosis should be considered in the differential diagnosis of abdominal wall masses in the patients with a history of abdominal surgery and cyclic painful solid mass.

  • Open Access

    Relationship Between Immunohistochemical CD3, CD4, CD5, CD8, and PD1 Staining and Histopathological Diagnosis of Cervical Lesions in Patients With Abnormal Colposcopic Findings

    by Ayhan Atigan, Tolga Güler, Yeliz Arman Karakaya, Derya Kilic

    Introduction: This study aimed to analyse the relationship between clinicopathological factors in cervical intraepithelial lesions and abnormal colposcopic findings. Material and methods: Thirty high-grade squamous intraepithelial lesion (HSIL) and thirty low-grade squamous intraepithelial lesion (LSIL) patients who underwent biopsy due to abnormal colposcopic findings were included in the study. The immunoreactivity of CD3, CD4, CD5, CD8, and PD-1 was analysed immunohistochemically in tumor-infiltrating lymphocytes (TILs) and stromal lymphocytes. Results: In TILs, CD3, CD4, CD5, CD8, and PD-1 were highly stained in 20/30 (66.6%), 16/30 (53.3%), 15/30 (50.0%), 24/30 (80.0%), and 13/30 (43.3%) of the cases for the HSIL group, while 7/30 (23.3%), 4/30 (13.3%), 5/30 (16.6%), 9/30 (30.0%), and 5/30 (16.6%) were in the LSIL group, respectively. CD3, CD4, CD5, CD8, and PD-1 immunostainings for TILs were higher in the HSIL group (p=0.001, p=0.001, p=0.006, p˂0.001, p=0.024, respectively). Only PD-1 was significantly higher in lymphocytes in the stroma (p=0.001). Conclusions: CD3, CD4, and CD8 also show a positive correlation with the Ki-67 proliferation index. CD3, CD4, CD5, and CD8 may contribute to PD-1-mediated tumour control. Immunohistochemical staining plays a key role in evaluating the tumour microenvironment.


  • Open Access

    Attitude and Practice Toward Use of Cigarettes and Electronic Cigarettes Among Pregnant Women: A Questionnaire-Based Survey

    by Elif Yıldırım, Serap Duru, Tülin Sevim, Füsun Topçu, Bilun Gemicioğlu, İpek Özmen, Birsen Ocaklı, Eylem Tuncay, Hilal Altınöz, Yaşam Kemal Akpak, et al.

    Smoking,pregnancy,regular tobacco cigarette,electronic cigarette,risk factors


  • The impact of uterine adenomyosis on the histopathological risk factors and survival in patients with endometrial adenocarcinoma

    by Mehmet Hakan Yetimalar, Derya Kilic, Incim Bezircioglu, Seyran Yigit

    A retrospective cohort study was performed on patients diagnosed with endometrial adenocarcinoma (EC) during a 9-year period to investigate the impact of co-existing adenomyosis on patients with EC. Group A included women with EC and adenomyosis and Group B EC cases without the presence of adenomyosis. Group A was more likely to have early-stage disease, tumours without deep myometrial invasion, low-grade tumours and tumours with negative lymphovascular space invasion when compared to Group B (p = 0.012, p = 0.004, p < 0.001, p = 0.02). There were no statistically significant difference between Group A and Group B for lymph node metastasis (p = 0.064). There was no significant relation between the adenomyosis and survival outcomes in the multivariant analysis (p = 0.437). As a conclusion, patients with adenomyosis were more likely to accompany good histopathologic prognostic factors. Multivariate analysis showed no significant effect of adenomyosis on recurrence and survival parameters.


  • Effects of isolated posterior vaginal wall prolapse on lower urinary tract symptoms

    by Derya Kilic, Tolga Guler, Ismail Gokbel, Deniz Akin Gokbel, Deniz Aydin Ceylan, Akin Sivaslioglu


  • Open Access

    Serum pregnancy-associated placental protein-a (PAPP-A) levels are increased in polycystic ovary syndrome (PCOS) in women with oligo-anovulation

    by Derya Kiliç, Ömer Tolga Güler

    Background/Aim: Pregnancy associated placental protein-A (PAPP-A) is a zinc-binding metalloproteinase with a key role in insulin like growth factor (IGF) pathway, and potential atherogenic effects. There is little information in the literature regarding PAPP-A levels in Polycystic ovary syndrome (PCOS). We aimed to investigate the serum PAPP-A levels among non-obese women with PCOS as a cardiovascular risk marker. Methods: Non-obese women of reproductive age (18-35 years of age) diagnosed with PCOS according to Rotterdam Consensus Conference criteria were included in this case-control study. Serum PAPP-A levels were compared with independent samples t-test between two main groups (PCOS and control) and investigated in PCOS subgroups as PCOS patients were further classified according to main phenotypes (hyperandrogenism and oligo-anovulation). Results: A total of 41 women with PCOS and 40 age- and body mass index- matched controls were included in the analysis. The serum PAPP-A levels of the control and PCOS groups, and of PCOS patients with hyperandrogenism were similar (P=0.128, P=0.261, respectively). However, the serum PAPP-A levels of those with oligo-anovulation was higher than those without (P=0.006), and that of women without oligo-anovulation was comparable to that of the control group (P=0.613). Conclusion: Lean and young PCOS women with oligo-anovulation had increased serum levels of PAPP-A when compared to women without. Prospective studies are needed to uncover the long-term cardiovascular risk of elevated PAPP-A levels in PCOS women with oligo-anovulation. '+st+' Dumesic DA, Oberfield SE, Stener-Victorin E, Marshall JC, Laven JS, Legro RS. Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome. Endocr Rev. 2015;36(5):487–525. Li Y, Chen C, Ma Y, Xiao J, Luo G, Li Y, Wu D. Multi-system reproductive metabolic disorder: significance for the pathogenesis and therapy of polycystic ovary syndrome (PCOS). Life Sci. 2019;228:167-75. Lizneva D, Suturina L, Walker W, Brakta S, Gavrilova-Jordan L, Azziz R. Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil Steril. 2016;106(1):6–15. Kilic D, Kilic ID, Sevgican CI, Kilic O, Alatas E, Arslan M, et al. Arterial stiffness measured by cardio-ankle vascular index is greater in non-obese young women with polycystic ovarian syndrome. J Obstet Gynaecol Res. 2020;4. doi: 10.1111/jog.14543. Delitala AP, Capobianco G, Delitala G, Cherchi PL, Dessole S. Polycystic ovary syndrome, adipose tissue and metabolic syndrome. Arch Gynecol Obstet. 2017;296(3):405–19. Torchen LC. Cardiometabolic Risk in PCOS: More than a Reproductive Disorder. Curr Diab Rep. 2017;17(12):137. Tsutsumi A. Prevention and management of work-related cardiovascular disorders. Int J Occup Med Environ Health. 2015;28(1):4–7. Calderon-Margalit R, Siscovick D, Merkin SS, Wang E, Daviglus ML, Schreiner PJ, et al. Prospective association of polycystic ovary syndrome with coronary artery calcification and carotid-intima-media thickness: the Coronary Artery Risk Development in Young Adults Women’s study. Arterioscler Thromb Vasc Biol. 2014;34(12):2688–94. Lin T-M, Halbert SP, Spellacy WN. Measurement of Pregnancy-Associated Plasma Proteins during Human Gestation. J Clin Invest. 1974;54(3):576–82. Steffensen LB, Conover CA, Oxvig C. PAPP-A and the IGF system in atherosclerosis: what’s up, what’s down? Am J Physiol Heart Circ Physiol. 2019;317(5):H1039–49. Consuegra-Sanchez L, Fredericks S, Kaski JC. Pregnancy-associated plasma protein-A (PAPP-A) and cardiovascular risk. Atherosclerosis. 2009;203(2):346–52. Conover CA, Bale LK. Loss of pregnancy-associated plasma protein A extends lifespan in mice. Aging Cell. 2007;6(5):727–9. Junnila RK, List EO, Berryman DE, Murrey JW, Kopchick JJ. The GH/IGF-1 axis in ageing and longevity. Nat Rev Endocrinol. 2013;9(6):366–76. Cirillo P, Conte S, Pellegrino G, Ziviello F, Barra G, De Palma R, et al. Pregnancy-associated plasma protein-A promotes TF procoagulant activity in human endothelial cells by Akt-NF-κB axis. J Thromb Thrombolysis. 2016;42(2):225–32. Firmansyah A, Chalid MT, Farid RB, Nusratuddin N. The correlation between insulin-like growth factor binding protein 1 (IGFBP-1) and homeostasis model assessment of insulin resistance (HOMA-IR) in polycystic ovarian syndrome with insulin resistance. Int J Reprod Biomed. 2018;16(11):679–82. Öztürk M, Öktem M, Altinkaya SÖ, Öktem EÖ, Elbeg Ş, Erdem A, et al. Elevated PAPP-A levels in lean patients with polycystic ovary syndrome. Taiwan J Obstet Gynecol. 2018 Jun;57(3):394-8. Giancarlo P, Helmut OS, Annette H, Jessica C, Ginger H, Marguerite KS, et al. Polycystic Ovary Syndrome Is Associated With Endothelial Dysfunction. Circulation. 2001;103(10):1410–5. Bajuk Studen K, Jensterle Sever M, Pfeifer M. Cardiovascular risk and subclinical cardiovascular disease in polycystic ovary syndrome. Front Horm Res. 2013;40:64–82. Glintborg D, Rubin KH, Nybo M, Abrahamsen B, Andersen M. Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome. Cardiovascular Diabetology. 2018;17(1):37. Oliver-Williams C, Vassard D, Pinborg A, Schmidt L. Risk of cardiovascular disease for women with polycystic ovary syndrome: results from a national Danish registry cohort study. Eur J Prev Cardiol. 2020;(2):2047487320939674. doi: 10.1177/2047487320939674. Carmina E, Lobo RA. Is There Really Increased Cardiovascular Morbidity in Women with Polycystic Ovary Syndrome? J Womens Health (Larchmt). 2018;27(11):1385–8. Daan NMP, Louwers YV, Koster MPH, Eijkemans MJC, de Rijke YB, Lentjes EWG, et al. Cardiovascular and metabolic profiles amongst different polycystic ovary syndrome phenotypes: who is really at risk? Fertil Steril. 2014;102(5):1444-1451.e3....